We are live on
!
Find out more
CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
122 hedge funds and large institutions have $524M invested in Clovis Oncology, Inc. in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 29 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
69% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 29
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
8% less call options, than puts
Call options by funds: $13.6M | Put options by funds: $14.8M
10% less funds holding
Funds holding: 135 → 122 (-13)
27% less capital invested
Capital invested by funds: $718M → $524M (-$194M)
32% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 37
Holders
122
Holders Change
-13
Holders Change %
-9.63%
% of All Funds
3.26%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
25
Increased
49
Reduced
29
Closed
37
Calls
$13.6M
Puts
$14.8M
Net Calls
-$1.25M
Net Calls Change
-$35.2M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$42.9M |
| 2 |
Morgan Stanley
New York
|
+$18.6M |
| 3 |
Goldman Sachs
New York
|
+$10.7M |
| 4 |
SC
Samlyn Capital
New York
|
+$9.92M |
| 5 |
HM
HealthCor Management
New York
|
+$9.5M |
Top Sellers
| 1 |
O
OppenheimerFunds
New York
|
-$23.9M |
| 2 |
PC
PointState Capital
New York
|
-$20M |
| 3 |
O
OrbiMed
New York
|
-$12.7M |
| 4 |
LPU
Lansdowne Partners (UK)
London,
United Kingdom
|
-$10.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.2M |
